Emil Kuriakose

Insider Reports History

Entity
Individual
Location
343 Oyster Point Blvd, Suite 200, South San Francisco, CA
Signature
/s/ David Strauss, as Attorney-in-Fact for Emil Kuriakose
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Emil Kuriakose:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Terns Pharmaceuticals, Inc. Chief Medical Officer Common Stock 58.8K $222K $3.78 Mar 10, 2024 Direct
Calithera Biosciences, Inc. CHIEF MEDICAL OFFICER Common Stock 3.54K $1.37K $0.39 Jan 23, 2023 Direct
Terns Pharmaceuticals, Inc. Chief Medical Officer Stock Option (Right to Buy) 120K Dec 12, 2024 Direct

Insider Reports Filed by Emil Kuriakose

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TERN Terns Pharmaceuticals, Inc. Dec 12, 2024 1 $0 4 Dec 16, 2024 Chief Medical Officer
TERN Terns Pharmaceuticals, Inc. Mar 10, 2024 0 $0 3 Mar 19, 2024 Chief Medical Officer
CALA Calithera Biosciences, Inc. Jan 23, 2023 1 -$35 4 Jan 25, 2023 CHIEF MEDICAL OFFICER
CALA Calithera Biosciences, Inc. Jan 25, 2022 1 $0 4 Jan 27, 2022 CHIEF MEDICAL OFFICER
CALA Calithera Biosciences, Inc. Jan 21, 2022 1 -$327 4 Jan 25, 2022 CHIEF MEDICAL OFFICER
CALA Calithera Biosciences, Inc. Jan 4, 2022 1 -$2.55K 4 Jan 6, 2022 CHIEF MEDICAL OFFICER
CALA Calithera Biosciences, Inc. Nov 5, 2021 2 -$2.68K 4 Nov 9, 2021 CHIEF MEDICAL OFFICER
CALA Calithera Biosciences, Inc. Nov 5, 2021 0 $0 3 Nov 9, 2021 CHIEF MEDICAL OFFICER